Clinical guidelines in development
This table lists NICE clinical guidelines in development. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also:
- click the guideline title for full details
- click a column heading to sort the list by that column.
More information on the clinical guidelines in development list.
You can also view the milestone dates for every guideline in development
Clinical guidelines in development
This page was last updated: 17 July 2015
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Appendix D diagnostic test accuracy - included studies (PDF 182 KB)
-
-
Appendix D non pharmacological risk factors - included studies (PDF 90 KB)
-
Appendix D pharmacological risk factors - included studies (PDF 49 KB)
-
Appendix E consequences of cohort studies - methodological quality (PDF 125 KB)
-
Appendix E diagnostic accuracy tests - methodological quality (PDF 172 KB)
-
Appendix E epidemiology - methodological quality (PDF 168 KB)
-
Appendix E non-pharmacological risk factors cohort studies - methodological quality (PDF 44 KB)
-
Appendix E pharmacological risk factors cohort studies - methodological quality (PDF 29 KB)
-
Appendix E patient information - methodological quality (PDF 213 KB)
-
Appendix F consequences of - multivariate risk factors (PDF 185 KB)
-
Appendix F - non-pharmacological risk factors - multivariate risk factors (PDF 293 KB)
-
Appendix F pharmacological risk factors - multivariate risk factors (PDF 63 KB)
-
Appendix G diagnostic test accuracy - excluded studies (PDF 128 KB)
-
Appendix G adverse effects review - excluded studies (PDF 121 KB)
-
-
Appendix G epidemiology review - excluded studies (PDF 146 KB)
-
Appendix G non-pharmacological risk factors - excluded studies (PDF 71 KB)
-
Appendix G information for patients review - excluded studies (PDF 118 KB)
-
Appendix G pharmacological risk factors - excluded studies (PDF 55 KB)
-
-
-
-
-
Consultation table and with developers responses (PDF 1.02 MB)
-
Pre-publication check - stakeholder comments/developer responses (PDF 49 KB)
-
-
-
-
-
Appendix D - Adverse Effects - Included studies (PDF 121 KB)
-
Appendix D - Consequences of - Included studies (PDF 155 KB)
-
Appendix D - Diagnostic Test Accuracy - Included Studies (PDF 182 KB)
-
-
Appendix D - Non pharmacological Risk factor - Included studies (PDF 44 KB)
-
Appendix D - Pharma Nonpharma Prevention Treatment - Included studies (PDF 170 KB)
-
Appendix D - Pharmacological Risk factors - Included studies (PDF 49 KB)
-
-
Appendix E - Diagnostic Accuracy Tests Methodological Quality (PDF 172 KB)
-
-
-
-
Appendix E - Pharma NonPharma Prevention Treatment (PDF 107 KB)
-
Appendix E - Pharmacological Risk Factors review - Randomised controlled trials (PDF 23 KB)
-
Appendix E - Pharmacological Risk Factors review - cohort studies (PDF 30 KB)
-
-
Appendix H - Recommendations for Future Research (PDF 75 KB)
-
-
-
-
Consultation table and with developers responses (PDF 1.02 MB)